[1] Zhi N, Ren RJ, Qi JL, Liu XY, Yun ZK, Lin SH, et al. The China Alzheimer report 2025. Gen Psychiatr 2025;38(4):e102020. https://doi.org/10.1136/gpsych-2024-102020.
[2] Chen XX, Giles J, Yao Y, Yip W, Meng QQ, Berkman L, et al. The path to healthy ageing in China: a Peking University–Lancet Commission. Lancet 2022;400(10367):1967 − 2006. https://doi.org/10.1016/S0140-6736(22)01546-X.
[3] Sallim AB, Sayampanathan AA, Cuttilan A, Chun-Man Ho R. Prevalence of mental health disorders among caregivers of patients with Alzheimer disease. J Am Med Dir Assoc 2015;16(12):1034 − 41. https://doi.org/10.1016/j.jamda.2015.09.007.
[4] Wang HL, Xie HG, Qu QM, Chen W, Sun YA, Zhang N, et al. The continuum of care for dementia: needs, resources and practice in China. J Glob Health 2019;9(2):020321. https://doi.org/10.7189/jogh.09.020321.
[5] Lang LD, Clifford A, Wei L, Zhang DM, Leung D, Augustine G, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open 2017;7(2):e011146. https://doi.org/10.1136/bmjopen-2016-011146.
[6] Chen RL, Hu Z, Chen RL, Ma Y, Zhang DM, Wilson K. Determinants for undetected dementia and late-life depression. Br J Psychiatry 2013;203(3):203 − 8. https://doi.org/10.1192/bjp.bp.112.119354.
[7] Qi SG, Zhang H, Guo HY, Wu J, Wang ZH. Undetected dementia in community-dwelling older people — 6 provincial-level administrative divisions, China, 2015−2016. China CDC Wkly 2020;2(38):731 − 5. https://doi.org/10.46234/ccdcw2020.200.
[8] Zhao M, Lv XZ, Tuerxun M, He JC, Luo BY, Chen W, et al. Delayed help seeking behavior in dementia care: preliminary findings from the Clinical Pathway for Alzheimer’s Disease in China (CPAD) study. Int Psychogeriatr 2016;28(2):211 − 9. https://doi.org/10.1017/S1041610215000940.
[9] Xiao JW, Li JP, Wang JT, Zhang XY, Wang C, Peng GP, et al. 2023 China Alzheimer’s disease: facts and figures. Hum Brain 2023;2(3):1-13. http://dx.doi.org/10.37819/hb.3.1771.
[10] Cai XX, Zhang YY, Shi C, Wong GHY, Luo H, Wang HL. Prescription of nonpharmacologic interventions in memory clinics: data from the Clinical Pathway for Alzheimer’s Disease in China (CPAD) study. J Am Med Dir Assoc 2024;25(12):105273. https://doi.org/10.1016/j.jamda.2024.105273.
[11] Tzeng HM, Raji MA, Shan Y, Cram P, Kuo YF. Annual wellness visits and early dementia diagnosis among Medicare beneficiaries. JAMA Netw Open 2024;7(10):e2437247. https://doi.org/10.1001/jamanetworkopen.2024.37247.
[12] Simpson V, Edwards N, Kovich M. Conversations about wellness: a qualitative analysis of patient narratives post annual wellness visit. Geriatr Nurs 2021;42(3):681 − 6. https://doi.org/10.1016/j.gerinurse.2021.03.001.
[13] Cox CG, Kirch M, Singer D, Solway E, Malani PN, Kullgren JT, et al. Older US adults’ experiences with and views about cognitive screening and blood biomarker testing for Alzheimer’s disease. Alzheimers Dement 2025;17(1):e70067. https://doi.org/10.1002/dad2.70067.
[14] Hampel H, Au R, Mattke S, van der flier WM, Aisen P, Apostolova L, et al. Designing the next-generation clinical care pathway for Alzheimer’s disease. Nat Aging 2022;2(8):692 − 703. https://doi.org/10.1038/s43587-022-00269-x.
[15] Hampel H, Vergallo A, Iwatsubo T, Cho M, Kurokawa K, Wang HL, et al. Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementation. Alzheimers Dement 2022;18(10):1993 − 2002. https://doi.org/10.1002/alz.12655.
[16] Luo YT, Guan X, Xiong Q, Wang HL. Evolution of strategic framework of policies related to dementia care and prevention in China from 2000 to 2024. Lancet Reg Health West Pac 2025;58:101561. https://doi.org/10.1016/j.lanwpc.2025.101561.
[17] National Health Commission of the People’s Republic of China, National Development and Reform Commission of the People’s Republic of China, Ministry of Education of the People’s Republic of China, Ministry of Science and Technology of the People’s Republic of China, Ministry of Public Security of the People’s Republic of China, Ministry of Civil Affairs of the People’s Republic of China, et al. National action plan on dementia prevention and control (2024-2030). 2025. https://www.nhc.gov.cn/lljks/c100158/202501/4b4476877f21467fbfcea71bc90d8313.shtml. [2025-9-7]. (In Chinese).
[18] Zhang HF, Loi SM, Zhou S, Zhao M, Lv XZ, Wang J, et al. Dementia literacy among community-dwelling older adults in urban China: a cross-sectional study. Front Public Health 2017;5:124. https://doi.org/10.3389/fpubh.2017.00124.
[19] Qiu SX, Zhao M, Zhang HF, Li T, Kuang WH, Liu S, et al. Heterogeneity in the level of dementia literacy among community doctors in China: a latent profile analysis. J Glob Health 2024;14:04161. https://doi.org/10.7189/jogh.14.04161.
[20] Zhang XY, Zhang M, Li T, Liu S, Zhang HF, Cheng HQ, et al. Knowledge, attitudes, and practice (KAP) of old age mental health among Chinese medical undergraduate students: a cross-sectional study. BMC Med Educ 2025;25(1):814. https://doi.org/10.1186/s12909-025-07363-9.
[21] Milne A. The ‘D’ word: reflections on the relationship between stigma, discrimination and dementia. J Ment Health 2010;19(3):227 − 33. https://doi.org/10.3109/09638231003728166.
[22] Wang HL, Yu X. Strengthening implementation research on social prescribing in mental healthcare for older adults in Western Pacific Region. Lancet Reg Health West Pac 2023;35:100721. https://doi.org/10.1016/j.lanwpc.2023.100721.
[23] Lin ZE, Ba F, Allore H, Liu GG, Chen X. Geographic variation in inpatient care utilization, outcomes and costs for dementia patients aged 65 years or older — China, 2017-2019. China CDC Wkly 2022;4(45):997 − 1001. https://doi.org/10.46234/ccdcw2022.202.